EDGAR Filing Documents for 0001607062-15-000271

Form 8-K - Current report:

SEC Accession No. 0001607062-15-000271

Filing Date

2015-06-25

Accepted

2015-06-25 14:41:02

Documents

Period of Report

2015-06-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gnbt082515form8k.htm	8-K	43353
2	EXHIBIT 3.1	ex3_1.htm	EX-3.1	172641
3	EXHIBIT 4.1	ex4_1.htm	EX-4.1	198131
4	EXHIBIT 4.2	ex4_2.htm	EX-4.2	86201
5	EXHIBIT 4.3	ex4_3.htm	EX-4.3	133435
6	EXHIBIT 99.1	ex99_1.htm	EX-99.1	13553
	Complete submission text file	0001607062-15-000271.txt		648641

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)